BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu R, Yang J, Ren B, Wang H, Yang G, Chen Y, You L, Zhao Y. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies. Front Oncol 2020;10:572722. [PMID: 33117704 DOI: 10.3389/fonc.2020.572722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kang BW, Chau I. Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials. Expert Opin Investig Drugs 2021;:1-19. [PMID: 34727804 DOI: 10.1080/13543784.2021.1995354] [Reference Citation Analysis]
2 Manoukian P, Bijlsma M, van Laarhoven H. The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth. Front Cell Dev Biol 2021;9:743907. [PMID: 34646829 DOI: 10.3389/fcell.2021.743907] [Reference Citation Analysis]
3 Ma Y, Ma Y. Hypergraph-based Logistic Matrix Factorization for Metabolite-disease Interaction Prediction. Bioinformatics 2021:btab652. [PMID: 34499104 DOI: 10.1093/bioinformatics/btab652] [Reference Citation Analysis]
4 Dong W, Liu X, Yang C, Wang D, Xue Y, Ruan X, Zhang M, Song J, Cai H, Zheng J, Liu Y. Glioma glycolipid metabolism: MSI2-SNORD12B-FIP1L1-ZBTB4 feedback loop as a potential treatment target. Clin Transl Med 2021;11:e411. [PMID: 34047477 DOI: 10.1002/ctm2.411] [Reference Citation Analysis]
5 Rajagopal MU, Bansal S, Kaur P, Jain SK, Altadil T, Hinzman CP, Li Y, Moulton J, Singh B, Bansal S, Chauthe SK, Singh R, Banerjee PP, Mapstone M, Fiandaca MS, Federoff HJ, Unger K, Smith JP, Cheema AK. TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC. Cancers (Basel) 2021;13:6204. [PMID: 34944824 DOI: 10.3390/cancers13246204] [Reference Citation Analysis]
6 Ma J, Xue H, He LH, Wang LY, Wang XJ, Li X, Zhang L. The Role and Mechanism of Autophagy in Pancreatic Cancer: An Update Review. Cancer Manag Res 2021;13:8231-40. [PMID: 34754243 DOI: 10.2147/CMAR.S328786] [Reference Citation Analysis]
7 Bhingarkar A, Vangapandu HV, Rathod S, Hoshitsuki K, Fernandez CA. Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias. Front Oncol 2021;11:694526. [PMID: 34277440 DOI: 10.3389/fonc.2021.694526] [Reference Citation Analysis]
8 Wang S, Zheng Y, Yang F, Zhu L, Zhu XQ, Wang ZF, Wu XL, Zhou CH, Yan JY, Hu BY, Kong B, Fu DL, Bruns C, Zhao Y, Qin LX, Dong QZ. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Ther 2021;6:249. [PMID: 34219130 DOI: 10.1038/s41392-021-00659-4] [Reference Citation Analysis]